The DOI matches its Crossref record; 243 of the 244 references it cites were found in a registry or an index.
Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease
Abstract
Alzheimer's disease (AD) is a neurodegenerative disease, in which the primary etiology remains unknown. AD presents amyloid beta (Aβ) protein aggregation and neurofibrillary plaque deposits. AD shows oxidative stress and chronic inflammation. In AD, canonical Wingless-Int (Wnt)/β-catenin pathway is downregulated, whereas peroxisome proliferator-activated receptor γ (PPARγ) is increased. Downregulation of Wnt/β-catenin, through activation of glycogen synthase kinase-3β (GSK-3β) by Aβ, and inactivation of phosphatidylinositol 3-kinase/Akt signaling involve oxidative stress in AD. Cannabidiol (CBD) is a non-psychotomimetic phytocannabinoid from Cannabis sativa plant. In PC12 cells, Aβ-induced tau protein hyperphosphorylation is inhibited by CBD. This inhibition is associated with a downregulation of p-GSK-3β, an inhibitor of Wnt pathway. CBD may also increase Wnt/β-catenin by stimulation of PPARγ, inhibition of Aβ and ubiquitination of amyloid precursor protein. CBD attenuates oxidative stress and diminishes mitochondrial dysfunction and reactive oxygen species generation. CBD suppresses, through activation of PPARγ, pro-inflammatory signaling and may be a potential new candidate for AD therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In PC12 neuronal cells, CBD has shown protection against oxidative stress, Aβ-induced neurotoxicity, inhibition of tau hyperphosphorylation, prevention of proinflammatory gene transcription, and inhibition of Aβ-induced tau hyperphosphorylation [188,189].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [188]
In the citing paper
“In PC12 neuronal cells, CBD has shown protection against oxidative stress, Aβ-induced neurotoxicity, inhibition of tau hyperphosphorylation, prevention of proinflammatory gene transcription, and inhibition of Aβ-induced tau hyperphosphorylation [188,189].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [188]
In the citing paper
“In PC12 neuronal cells, CBD has shown protection against oxidative stress, Aβ-induced neurotoxicity, inhibition of tau hyperphosphorylation, prevention of proinflammatory gene transcription, and inhibition of Aβ-induced tau hyperphosphorylation [188,189].”
From The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment (2022) · cites this paper as [188]
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
The Global Deterioration Scale for assessment of primary degenerative dementia
Reisberg, ., Ferris, S. H., de Leon, M. J., & Crook, T. H. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.9.1136 · Cited by 5,122
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Signaling to NF-κB by Toll-like receptors
Kawai, T., & Akira, S. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.002 · Cited by 2,468
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Flagged first, then by citations
1 of the 244 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Martín-Moreno AM, Reigada D, Ramírez BG, Mechoulam R, Innamorato N, Cuadrado A. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Mol Pharmacol, 2011, 79: 964-973. · DOI
- Sonego AB, Sepulveda-Diaz JE, Michel PP, Del-Bel EA, Guimarães FS, Raisman-Vozari R. Cannabidiol reduces LPS-induced activation and oxidative stress in primary microglial culture via PPARgamma receptor. Soc Neurosci Annu Meet, 2015, 58:
Cited by
Sorted by citations
Items 201–228 of 228
Behavioural and molecular effects induced by Cannabidiol in animal models of depression
Silote, G. P. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.60.2021.tde-29092021-060118
Medical use of cannabidiol and impact on cancer cell viability
Raup‐Konsavage, W. M., & Vrana, K. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90036-2.00027-2
Modulation of neuroinflammation by natural molecules
Maurya, S. K., & Mishra, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00008-7
Gavioli, A., Cadeu, A. B., Laurentino, G. C., & Ortiz, S. R. M. (2024) · Journal Archives of Health · doi:10.46919/archv5n1-007 · Cited by 2
Additional file 2 of Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
Wang, H., Han, X., & Gao, S. (2021) · Figshare · doi:10.6084/m9.figshare.14913752
Additional file 3 of Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
Wang, H., Han, X., & Gao, S. (2021) · Figshare · doi:10.6084/m9.figshare.14913755
Marra, B. C., Guimarães, L. D., & Costa, S. H. N. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n4-179
Nutraceuticals in the Treatment of Hair Loss
Rogers, N. E. (2024) · Updates in clinical dermatology · doi:10.1007/978-3-031-74314-6_7
Reece, A. S., & Hulse, G. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13492-0.00027-x
Research Progress on Signaling Pathways Involved in Treating Osteoporosis with Isopsoralen
Jin, H., Shuai, B., Huang, C. P., Wang, D., He, Z., Shen, L., Chen, M., & Wang, Z. (2025) · Current Traditional Medicine · doi:10.2174/0122150838378545250707100938
Kornsuthisopon, C., Chansaenroj, A., Vimolmangkang, S., Samaranayake, L. P., & Osathanon, T. (2025) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.70081
Additional file 1 of Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
Wang, H., Han, X., & Gao, S. (2021) · Figshare · doi:10.6084/m9.figshare.14913749
Cannabidiol and neurodevelopment: Is perception outpacing proof?
Ulaganathan, G., & Murphy, S. K. (2025) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2025.100569
Zarei, H. R. A., Gholami, M., Ghazalian, F., & Ghareh, S. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11573-9 · Cited by 1
Vallée, A. (2017) · theses.fr (ABES) · doi:10.70675/e07edff7z4f56z4165z8ee2z475c4aafb600
Self-citationHuman limbal stem cell regulation : importance of Wnt signaling pathway
Bonnet, C. (2022) · theses.fr (ABES) · doi:10.70675/1945db5dz72d5z45efzb303z598eb41c6048
Cannabidiol and diabetic heart disease: Mechanistic evidence and translational challenges
Arowolo, A., Adeyemı, O. S., Ajonijebu, T. E., Musa, A., Mutavhatsindi, H., Johnson, R., & Obikeze, K. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119354
Khozani, M. S., Palizvan, M. R., Mosayebi, G., Ganji, A., & Ghazavi, A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02163-z · Cited by 1
Huang, Y., Zhou, J., Wang, W., Ning, Z., Kong, X., Zhu, K., Liu, Z., & Mu, W. (2026) · Animals · doi:10.3390/ani16091338
Cannabinoid impacts on ethnic modulation of atrial septal defect prevalence USA
Reece, A. S., & Hulse, G. K. (2026) · Journal of Perinatology · doi:10.1038/s41372-026-02717-7
Kim, J. I., Yeo, H., Jo, Y., Kim, H., Park, S., & Kim, N. S. (2026) · Pain Research and Management · doi:10.1155/prm/3334432
Non-psychoactive phytocannabinoids in the therapy of skin diseases
Gęgotek, A., Jarocka-Karpowicz, I., Mucha, M., & Skrzydlewska, E. (2026) · Studies in natural products chemistry · doi:10.1016/b978-0-443-49142-9.00002-0
The beneficial properties of CBDA in diet-induced neuroinflammation
Konstantynowicz-Nowicka, K., Opęchowska, A., Domalewski, M., Zabielska-Kaczorowska, M. A., Bogucka, A. E., Lipiński, M., Harasim‐Symbor, E., & Chabowski, A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02358-4
Kalra, P., Chaturvedi, D., Kumar, A., Grewal, A. K., Khan, H., Singh, V., Singh, T. G., Singh, T., Ahmad, S. F., & Attia, S. M. (2026) · NeuroMolecular Medicine · doi:10.1007/s12017-026-08947-4
Rachelle, É. F., Vanz, J. B., Hennig, B. D. L., Roman, S. S., Steffens, J., & Steffens, C. (2026) · Applied Sciences · doi:10.3390/app16189171
Moatamed, R. S., Michel, D. L., Elessawy, F., Purves, R. W., Laprairie, R. B., & El‐Aneed, A. (2026) · Journal of Mass Spectrometry · doi:10.1002/jms.70119
Sura, S., Jagadeesan, S., Masrudin, S. S., Moklas, M. A. M., & Nor, N. H. M. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-13034-9
Metadata
- Authors
- Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Acta Biochimica et Biophysica Sinica
- Published
- 2017-10-01
- Volume
- 49
- Issue
- 10
- Pages
- 853-866
- ISSN
- 1672-9145 (ISSN-L)
- OpenAlex
- W2738129635
- Cited by
- 226
- References
- 244
- Citations by year
- 2026: 20 · 2025: 17 · 2024: 26 · 2023: 29 · 2022: 37 · 2021: 37 · 2020: 31 · 2019: 16 · 2018: 9 · 2017: 4
- FWCI
- 12.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Acta Biochimica et Biophysica Sinica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Keywords
- cannabidiol, Alzheimer's disease, Wnt/β-catenin signaling, PPARγ, oxidative stress, neuroinflammation, amyloid-beta, glycogen synthase kinase-3β, tau hyperphosphorylation, phosphatidylinositol 3-kinase/Akt signaling, mitochondrial dysfunction, reactive oxygen species, neuroprotection
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Alzheimer Disease, Animals, Cannabidiol, Inflammation, Models, Biological, Phosphorylation, Amyloid beta-Peptides, PC12 Cells, Neurofibrillary Tangles, tau Proteins, Oxidative Stress, PPAR gamma, Rats, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
